C[C@H]1CN(C(=O)c2nc3ccc(Cl)cn3c2CNCC[C@@H]2C[C@@H]3C=C[C@H]2C3)C[C@@H](C)O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?